rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6 Pt 1
|
pubmed:dateCreated |
1998-2-2
|
pubmed:abstractText |
Lately, renewed interest has arisen in the new forms of allergen immunotherapy because they may offer alternatives for drug treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0091-6749
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
100
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
721-7
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:9438477-Adult,
pubmed-meshheading:9438477-Allergens,
pubmed-meshheading:9438477-Animals,
pubmed-meshheading:9438477-Antigens, Plant,
pubmed-meshheading:9438477-Asthma,
pubmed-meshheading:9438477-Binding, Competitive,
pubmed-meshheading:9438477-Blotting, Western,
pubmed-meshheading:9438477-Cattle,
pubmed-meshheading:9438477-Clone Cells,
pubmed-meshheading:9438477-Desensitization, Immunologic,
pubmed-meshheading:9438477-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:9438477-Female,
pubmed-meshheading:9438477-Histamine Release,
pubmed-meshheading:9438477-Humans,
pubmed-meshheading:9438477-Immunoglobulin E,
pubmed-meshheading:9438477-Lymphocyte Activation,
pubmed-meshheading:9438477-Male,
pubmed-meshheading:9438477-Middle Aged,
pubmed-meshheading:9438477-Peptide Fragments,
pubmed-meshheading:9438477-Proteins,
pubmed-meshheading:9438477-Recombinant Proteins,
pubmed-meshheading:9438477-Skin Tests,
pubmed-meshheading:9438477-T-Lymphocytes
|
pubmed:year |
1997
|
pubmed:articleTitle |
Recombinant allergen fragments as candidate preparations for allergen immunotherapy.
|
pubmed:affiliation |
Department of Clinical Microbiology, University of Kuopio, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|